Perspective - (2025) Volume 11, Issue 4
Received: 01-Jul-2025, Manuscript No. ohcr-25-174299;
Editor assigned: 03-Jul-2025, Pre QC No. P-174299;
Reviewed: 17-Jul-2025, QC No. Q-174299;
Revised: 22-Jul-2025, Manuscript No. R-174299;
Published:
29-Jul-2025
, DOI: 10.37421/2471-8726.2025.11.207
Citation: Hughes, Daniel. ”Odontogenic Cysts and Tumors: Diagnosis to Therapeutics.” Oral Health Case Rep 11 (2025):207.
Copyright: © 2025 Hughes D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
This study provides a retrospective analysis of odontogenic cysts and tumors, detailing their frequency, age, gender distribution, and anatomical location. It highlights the predominance of odontogenic keratocysts among cysts and ameloblastomas among tumors, underscoring the importance of accurate diagnosis for effective management in a clinical setting [1].
This review discusses the evolving understanding of odontogenic keratocyst, focusing on its diagnosis through clinical, radiographic, and histopathological features. It outlines various contemporary management strategies, including surgical and conservative approaches, emphasizing the importance of individualized treatment plans to prevent recurrence given its aggressive nature [2].
This systematic review and meta-analysis critically evaluates the recurrence rates of odontogenic keratocysts when treated with either decompression or enucleation. The findings provide evidence-based insights into the comparative efficacy of these two common surgical approaches, guiding clinicians in selecting optimal treatment strategies to minimize disease recurrence [3].
This comprehensive review explores the significant genetic alterations implicated in the development and progression of various odontogenic tumors. It highlights specific molecular pathways and gene mutations that contribute to their pathogenesis, offering insights into potential diagnostic biomarkers and therapeutic targets for improved patient management and prognosis [4].
This contemporary review offers a detailed look at ameloblastoma, covering its intricate pathogenesis, key diagnostic features across clinical and radiographic modalities, and current treatment strategies. It emphasizes the importance of multidisciplinary approaches in managing this locally aggressive odontogenic tumor to optimize outcomes and minimize recurrence [5].
This comprehensive review on ameloblastoma delves into its diagnostic modalities, various treatment options, and significant molecular underpinnings. It highlights recent advances in understanding the genetic and cellular pathways involved, providing a foundation for targeted therapies and improved precision in patient management [6].
This study presents a 10-year clinicopathological analysis of odontogenic tumors encountered at a major tertiary care center. It details the prevalence, demographic profiles, and histological subtypes, contributing valuable epidemiological data and insights into the regional presentation and characteristics of these diverse oral pathologies [7].
This article provides a comprehensive review of Calcifying Epithelial Odontogenic Tumor (Pindborg tumor), discussing its clinical presentation, radiological features, histopathology, and differential diagnosis. It includes a case report to illustrate the typical characteristics and management considerations for this rare odontogenic tumor [8].
This systematic review synthesizes current knowledge on the molecular mechanisms driving ameloblastoma development and explores potential targeted therapeutic approaches. It identifies key signaling pathways and genetic mutations, paving the way for novel precision medicine strategies that could improve treatment outcomes for patients with this challenging tumor [9].
This literature review examines the role of Epithelial-Mesenchymal Transition (EMT) in the progression and invasiveness of odontogenic tumors. It highlights how EMT pathways contribute to the aggressive biological behavior of these lesions, offering insights into potential targets for therapeutic intervention aimed at inhibiting tumor growth and metastasis [10].
Retrospective analyses of odontogenic cysts and tumors offer crucial insights into their epidemiology, detailing their frequency, age, gender distribution, and precise anatomical locations within the oral cavity. Such studies consistently report a notable predominance of odontogenic keratocysts among all cysts and ameloblastomas among tumors, emphasizing that an accurate and timely diagnosis is paramount for effective management in clinical settings [1]. Building on this, extensive clinicopathological analyses, derived from observations over considerable periods like a decade at major tertiary care centers, further enrich the epidemiological landscape. These provide valuable, detailed data concerning the prevalence rates, demographic profiles, and specific histological subtypes of these diverse oral pathologies, significantly contributing to regional understanding of their presentation and characteristics [7].
The understanding and management of odontogenic keratocysts are continually evolving. Current reviews primarily focus on refining diagnosis through a careful integration of clinical, radiographic, and histopathological features. Furthermore, these reviews meticulously outline various contemporary management strategies, encompassing both advanced surgical interventions and more conservative approaches. Given the inherently aggressive nature of odontogenic keratocysts, the paramount importance of developing individualized treatment plans to effectively prevent recurrence is consistently emphasized [2]. To that end, a systematic review and meta-analysis provides a critical evaluation of the recurrence rates observed following two widely adopted surgical techniques: decompression versus enucleation. The evidence-based insights derived from these comparative studies are invaluable for guiding clinicians in their selection of optimal treatment strategies, ultimately aiming to minimize disease recurrence and improve patient outcomes [3].
Ameloblastoma stands out as a significant, locally aggressive odontogenic tumor, warranting extensive contemporary review. These detailed examinations cover its intricate pathogenesis, key diagnostic features identifiable through various clinical and radiographic modalities, and the evolving landscape of current treatment strategies. The consensus highlights the critical role of multidisciplinary approaches in managing this challenging tumor, aiming to optimize patient outcomes and significantly minimize the chances of recurrence [5]. Expanding on this, other comprehensive reviews meticulously delve into the diverse diagnostic modalities available, a spectrum of treatment options, and the profound molecular underpinnings of ameloblastoma. These reviews specifically underscore recent advances in comprehending the genetic and cellular pathways involved, thereby establishing a robust foundation for the development of highly targeted therapies and fostering improved precision in overall patient management [6].
Beyond general characteristics, understanding the genetic and molecular landscape is paramount. Comprehensive reviews explore the significant genetic alterations that are intricately implicated in the development and progression of various odontogenic tumors. These studies rigorously highlight specific molecular pathways and gene mutations directly contributing to their pathogenesis, offering crucial insights into potential diagnostic biomarkers and innovative therapeutic targets. This knowledge is fundamental for achieving improved patient management and predicting prognosis more accurately [4]. Focusing more narrowly on ameloblastoma, systematic reviews meticulously synthesize the current knowledge regarding the precise molecular mechanisms that drive its development. They concurrently explore promising potential targeted therapeutic approaches, specifically identifying key signaling pathways and genetic mutations. This groundbreaking work is paving the way for novel precision medicine strategies, which hold the potential to substantially improve treatment outcomes for individuals afflicted with this challenging tumor [9]. Furthermore, literature reviews delve into the critical role of Epithelial-Mesenchymal Transition (EMT) in influencing the progression and invasiveness of odontogenic tumors. They underscore how EMT pathways contribute profoundly to the aggressive biological behavior characteristic of these lesions, thereby offering compelling insights into potential targets for therapeutic intervention specifically aimed at inhibiting tumor growth and preventing metastasis [10].
The literature also extends to less common, yet clinically significant, odontogenic tumors. A comprehensive review, for instance, focuses on the Calcifying Epithelial Odontogenic Tumor, often referred to as Pindborg tumor. This detailed article thoroughly discusses its characteristic clinical presentation, distinctive radiological features, specific histopathology, and the crucial aspects of its differential diagnosis. To further enhance understanding and illustrate typical management considerations for this rare odontogenic tumor, the review often incorporates a pertinent case report [8].
The compiled research offers a comprehensive perspective on odontogenic cysts and tumors, covering their clinicopathological profiles, diagnostic methodologies, and management strategies. Studies highlight the prevalence of odontogenic keratocysts and ameloblastomas, emphasizing that accurate diagnosis is fundamental for effective patient care. Detailed analyses explore various treatment approaches, particularly for odontogenic keratocysts, where recurrence rates are a key concern when comparing techniques like decompression and enucleation. For ameloblastomas, the literature delves into their pathogenesis, diagnostic features, and the necessity of multidisciplinary treatment, alongside in-depth examinations of their molecular aspects and genetic underpinnings to identify potential targeted therapies. Broader investigations reveal significant genetic alterations contributing to the development and progression of odontogenic tumors, pointing towards new diagnostic biomarkers and therapeutic targets. Epidemiological studies provide valuable data on tumor prevalence and demographic characteristics, while specific reviews address rare tumors like Calcifying Epithelial Odontogenic Tumor (Pindborg tumor). Additionally, research into molecular mechanisms such as Epithelial-Mesenchymal Transition (EMT) sheds light on tumor invasiveness, suggesting avenues for interventions to curb growth and metastasis. This body of work collectively advances understanding to improve diagnosis, refine treatment, and explore novel therapeutic pathways for these oral pathologies.
None
None
1. Ankur M, Chakkalakunja S, Abhay K. "Clinicopathological profile of odontogenic cysts and tumors in a tertiary care center: A 5-year retrospective study.".Indian J Dent Res 34 (2023):263-268.
Indexed at, Google Scholar, Crossref
2. Chaithra K, Prasanna B, Manjula S. "Current concepts in the diagnosis and management of odontogenic keratocyst.".J Oral Maxillofac Pathol 27 (2023):162-171.
Indexed at, Google Scholar, Crossref
3. Zhimin Z, Ying G, Wei F. "Recurrence rate of odontogenic keratocyst after decompression versus enucleation: A systematic review and meta-analysis.".J Craniomaxillofac Surg 49 (2021):483-490.
Indexed at, Google Scholar, Crossref
4. Ajay Y, Vibha Y, Sukhvinder R. "Role of genetic alterations in the pathogenesis and prognosis of odontogenic tumors: A comprehensive review.".J Oral Maxillofac Pathol 25 (2021):114-123.
Indexed at, Google Scholar, Crossref
5. Vijay PS, Shivani R, Nidhi S. "Ameloblastoma: A contemporary review of pathogenesis, diagnosis, and treatment.".J Oral Maxillofac Pathol 24 (2020):125-132.
Indexed at, Google Scholar, Crossref
6. Miguel R, Joana C, Cláudia L. "Ameloblastoma: a comprehensive review of diagnosis, treatment and molecular aspects.".Med Oral Patol Oral Cir Bucal 27 (2022):e196-e205.
Indexed at, Google Scholar, Crossref
7. Nidhi S, Sakshi D, Sukhvinder R. "Clinicopathological study of odontogenic tumors: A 10-year experience at a tertiary care center.".J Oral Maxillofac Pathol 25 (2021):226-232.
Indexed at, Google Scholar, Crossref
8. Vaishali G, Amanpreet K, Rashmi S. "Calcifying epithelial odontogenic tumor (Pindborg tumor): A review of the literature with a case report.".J Oral Maxillofac Pathol 24 (2020):247-251.
Indexed at, Google Scholar, Crossref
9. Xin S, Shuangshuang Y, Shiqi S. "Molecular mechanisms and targeted therapies for ameloblastoma: A systematic review.".Oral Oncol 130 (2022):105915.
Indexed at, Google Scholar, Crossref
10. K S, Subramanyam N, Prasanna B. "Epithelial-Mesenchymal Transition in Odontogenic Tumors: A Literature Review.".J Contemp Dent Pract 24 (2023):1068-1073.
Oral Health Case Reports received 120 citations as per Google Scholar report